All applications must be lodged electronically through the department's website and must include a completed online application form.
An application must include:
- a completed online application form
- a written quote from the applicant for provision of the proposed services to the national or international client
- a letter of commitment from the national or international client
- the applicant's financial statements
- Signed declaration acknowledging acceptance by the applicant of the standard terms and conditions.
The Queensland Biomedical Voucher Program is a $1.5 million initiative designed to support opportunities for Queensland based biomedical suppliers to work with national and international clients to develop biomedical products.
The biomedical industry is one of the department's priority industry sectors, the growth of the industry will assist in diversifying the State's economy and create knowledge-based jobs for the future.
The Queensland Biomedical Voucher Program is a response to the industry's call for support in increasing awareness of Queensland-based biomedical industry and its capabilities and access to markets.
The Queensland Biomedical Voucher Program aims to:
- attract biomedical industry to Queensland
- increase the productivity and profile of the Queensland biomedical industry
- encourage non-Queensland-based businesses to collaborate with Queensland-based businesses and use Queensland-based biomedical capability to develop biomedical products
- enable Queensland-based businesses to collaborate and innovate with national and international businesses to develop biomedical products.
More information on the Biomedical Roadmap can be found on the department's website.
The proposed activity must:
- support development of a biomedical product
- commence within 6 months of being advised of funding approval
- be capable of being completed within 18 months of execution of a funding agreement.
No, the services must support the development of a biomedical product.
Each proposal will differ as to the stage at which services are being provided to support the biomedical product under development. The services should be supporting the advancement of the biomedical product through, for example, testing, development of a prototype or obtaining professional advice specific to the potential product under development.
Yes, provided the pre-clinical activities support the progression of the development of a biomedical product.
Grants of up to $250,000 (excluding GST) are available for successful applications.
The amount of funding sought from the Queensland Biomedical Voucher Program must be matched, in cash, on a dollar for dollar basis by the proposed national or international client nominated in the application form.
For example, if you apply for $250,000 (excluding GST), the proposed national or international client must commit to paying a minimum of $250,000 (excluding GST) toward the biomedical services to be provided by the applicant.
The commitment must be cash. In-kind payments are not considered cash.
The matching cash funding from the proposed national or international client is cash used to meet half the cost of obtaining the proposed biomedical services to be provided by the applicant, up to a cap of $250,000 (excluding GST).
No, but the application must include a letter of commitment from the chief financial officer, chief executive officer, or another duly authorised person from the proposed national or international client committing the funding should the application to the Program be successful.
Queensland-based companies or businesses providing biomedical services are eligible to apply, if they:
- provide services to support development of a biomedical product
- have a valid Australian Business Number (ABN) and be GST registered, or have evidence of a valid exemption
- are not related to the proposed national or international client.
For companies and businesses, Queensland-based means either:
- a Queensland-registered company or business that has Queensland as its principal place of business on the Australian Business Register, or
- a business that is not registered in Queensland but has a physical office in Queensland capable of providing biomedical services.
A Queensland-registered company or business means the Australian Business Number (ABN) and the Australian Business Register (ABR) Number must designate the organisation's principal place of business location as a Queensland address.
Yes. The applicant must have provided a written quote for the services to the proposed national or international client which clearly identifies the part of the fee that is to be paid by the national/international client and the part to be supported by the State, prior to applying and submit the quote with the application to the Queensland Biomedical Voucher Program.
Queensland Biomedical Voucher Program funding support can be used to meet 50% of the cost of obtaining, up to a maximum of $250,000 (excluding GST), eligible biomedical services provided by a Queensland-based biomedical service provider to support the development of a biomedical product.
Eligible services are services provided in Queensland by a Queensland-based biomedical service provider to support the development of a biomedical product which are detailed in the quote attached to the application. Examples of eligible services include:
- design development and validation services
- building or testing a prototype
- contract development and/or manufacturing services
- contract research services related to development of a biomedical product
- specialist advice or professional services including
- corporate structuring services, Australian incorporation costs and tax advice including R&D tax incentive advice
- intellectual property advice and intellectual property registration costs
- capital raising advice
- regulatory advice
- commercialisation advice and services
- cost of small items of plant and equipment (capital items) necessary to provide quoted biomedical services to the proposed national/international client as detailed in the application.
In alignment with the biomedical roadmap's targeted industries, 'biomedical product' includes the following:
- Medical devices and diagnostics
- Traditional and bio-pharmaceuticals
- Vaccines/drug discovery
- Complementary medicines
- Supporting digital technologies – including eHealth
No. Applications for funding support from the Queensland Biomedical Voucher Program must relate to new work which will commence on a date after the approval of the successful application to the Program.
All assessment criteria are weighted equally.
Funding will be paid in Australian dollars to the Queensland-based service provider in accordance with milestones contained the funding agreement between the successful applicant and the State through the department.
Milestones will be based on the payment milestones in the service contract between the Queensland-based supplier and the national or international client.
Queensland Biomedical Voucher Program funding support will be paid as and when and in the same proportion as the national or international client pays milestone payments.
The number of recipients will depend on the funding pool allocated to this funding round and the quality of the eligible applications submitted.
All applications must be submitted electronically through the online portal on the department's website. Documentation to support the application must be uploaded via the online portal.
Round 1 of the Queensland Biomedical Voucher Program will open on Thursday 26 April 2018 and close at 12.00 midday on Thursday 21 June 2018, Australian Eastern Standard Time.
No. All applications must be submitted by the application closing date and time.
Further rounds will depend on the number of application received in round 1 and quantum of funding allocated.
No. However, you must advise the department of any changes which are likely to adversely impact on eligibility.
Successful applicants will be required to execute a funding agreement with the State through the Department of State Development, Manufacturing, Infrastructure and Planning that outlines the terms of the grant and the milestone payment requirements.
Once notified of the outcome of your application, and if successful, the applicant must enter into a Funding Agreement with the Department prior to commencing the project.
The project must commence within 6 months of notification of approval of funding.
Services provided and costs incurred before the application is approved will not be able to be paid from Queensland Biomedical Voucher Program funding support.
Yes, where small items of plant and equipment are required to be purchased by the applicant to enable it to provide the proposed biomedical services, these items can be included in a proposal provided:
- the cost of the capital item is itemised in the quote to the national/international client
- the capital item is necessary to enable the applicant to provide biomedical services to the national/international client.
No. Funding support from the Queensland Biomedical Voucher Program is not available for existing projects where services have already commenced. Projects that are already underway are not eligible.
Only services provided after the application is approved can be paid for from funding support from the Queensland Biomedical Voucher Program.
No. Funding support cannot be used to extend an existing project, but can be used to undertake a new service agreement that builds on completed work undertaken in Queensland by an applicant and an existing national or international client.
Successful round 1 proposals must commence by no later than 6 months of being advised of funding approval and must be completed within 18 months of execution of a funding agreement.
All applications will be checked against the eligibility criteria:
- All eligible applications will be assessed by a panel of independent external assessors.
- Applications may also be subjected to due diligence and financial analysis.
- Assessments will be made against the assessment criteria contained in the published Queensland Biomedical Voucher Program Guidelines for applicants.
Yes, if applicants determine that they have more than one eligible project, they are able to submit more than one application.
Yes, provided the services are provided from premises located in Queensland.
No. The letter of commitment from the proposed national/international client must state:
- it is a company or business based outside of Queensland which does not have a subsidiary entity already established in Queensland.
No, a Queensland Government department cannot be an applicant.
No, a Queensland Government department cannot be an applicant.
Yes, a Queensland private hospital can be an applicant if it meets all of the eligibility criteria.
No. The guidelines require that the letter of commitment from the client confirm that they are a company or business based outside of Queensland which does not have a subsidiary entity already established in Queensland.
Yes. The Program has appropriate processes in place to manage commercially sensitive information contained in applications.
Applicants should note that if an application is successful, the overall quantum and timing of funding provided, as well as the successful applicant's name, the national/international client's name and a brief description of the Queensland-based biomedical service provider providing services and a general description of the services obtained, will be made public.
Successful applicants must:
- enter into a funding agreement with the State of Queensland through the Department of State Development, Manufacturing, Infrastructure and Planning
- enter into a service contract with the national/international client to conduct the work in Queensland as detailed in the successful application
- complete the proposed services within 18 months of execution of the funding agreement.
The template Queensland Biomedical Voucher Program funding agreement is published on the department's website.